Literature DB >> 27858181

Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas.

Dakeun Lee1, In-Hye Ham2,3, Sang Yong Son2, Sang-Uk Han2, Young-Bae Kim4, Hoon Hur5,6,7.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prognostic significance of the intratumor stromal proportion in gastric signet ring cell (SRC) carcinomas.
BACKGROUND: Cancer stroma, as exemplified by cancer-associated fibroblasts (CAFs), plays critical roles in cancer proliferation, invasion, and metastasis.
METHODS: One hundred seventy-five SRC carcinoma cases were classified according to the intratumor desmoplastic stromal proportion to then analyze the clinicopathologic characteristics of stroma-rich cases. We also investigated the impact of CAFs on the migration as well as on the phenotypic changes of gastric SRC carcinomas in vitro. Furthermore, we performed RNA sequencing of a pair of CAFs and normal-tissue-associated fibroblasts.
RESULTS: Stroma-rich SRC carcinomas (64 of 175 cases, 36.5%) were associated with female patients (P = 0.045), large tumor size (P = 0.007), higher T category (P < 0.001), and the presence of perineural invasion (P = 0.018). Patients with stroma-rich SRC carcinomas had a significantly shorter disease-free survival (P < 0.001) and overall survival (P < 0.001). However, in a subgroup analysis, the prognostic significance of the stromal proportion correlated only with patients with T3/4 disease. From multivariate analysis, the high stromal proportion is an independent prognostic factor to predict worse disease-free survival (hazard ratio 2.288; P = 0.001) and overall survival (hazard ratio 2.503; P = 0.001). We found that CAFs enhanced the migratory abilities of cancer cells through the epithelial-mesenchymal transition, and RNA sequencing results confirmed these findings.
CONCLUSIONS: The intratumor stromal proportion could be a useful prognostic biomarker and a potential therapeutic target in gastric SRC carcinomas.

Entities:  

Keywords:  Cancer-associated fibroblast; Gastric cancer; Intratumor stromal proportion; Prognosis; Signet ring cell carcinoma

Mesh:

Year:  2016        PMID: 27858181     DOI: 10.1007/s10120-016-0669-2

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  34 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Epithelium-mesenchyme transition during neural crest development.

Authors:  J L Duband; F Monier; M Delannet; D Newgreen
Journal:  Acta Anat (Basel)       Date:  1995

3.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

4.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

5.  Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.

Authors:  Ziliang Qian; Guanshan Zhu; Lili Tang; Mei Wang; Lianhai Zhang; Jiangang Fu; Chunlei Huang; Shuqiong Fan; Yun Sun; Jing Lv; Hua Dong; Beirong Gao; Xinying Su; Dehua Yu; Jie Zang; Xiaolin Zhang; Jiafu Ji; Qunsheng Ji
Journal:  Genes Chromosomes Cancer       Date:  2014-06-17       Impact factor: 5.006

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

7.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

8.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

Authors:  A Bergamaschi; E Tagliabue; T Sørlie; B Naume; T Triulzi; R Orlandi; H G Russnes; J M Nesland; R Tammi; P Auvinen; V-M Kosma; S Ménard; A-L Børresen-Dale
Journal:  J Pathol       Date:  2008-02       Impact factor: 7.996

9.  The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.

Authors:  Wilma E Mesker; Jan M C Junggeburt; Karoly Szuhai; Pieter de Heer; Hans Morreau; Hans J Tanke; Rob A E M Tollenaar
Journal:  Cell Oncol       Date:  2007       Impact factor: 6.730

10.  TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer.

Authors:  Satoshi Fujii; Ayano Fujihara; Kei Natori; Anna Abe; Yasutoshi Kuboki; Youichi Higuchi; Masaki Aizawa; Takeshi Kuwata; Takahiro Kinoshita; Wataru Yasui; Atsushi Ochiai
Journal:  Cancer Med       Date:  2015-09-04       Impact factor: 4.452

View more
  20 in total

1.  Secretome analysis reveals reduced expression of COL4A2 in hypoxic cancer-associated fibroblasts with a tumor-promoting function in gastric cancer.

Authors:  Seo-Gyu Park; Mi-Jung Ji; In-Hye Ham; Yoon-Hee Shin; Su-Min Lee; Chang Hoon Lee; Eunjung Kim; Hoon Hur; Hyun-Mee Park; Jae-Young Kim
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-20       Impact factor: 4.322

Review 2.  Modeling the process of human tumorigenesis.

Authors:  Sneha Balani; Long V Nguyen; Connie J Eaves
Journal:  Nat Commun       Date:  2017-05-25       Impact factor: 14.919

Review 3.  Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.

Authors:  Seema Gupta; Amrita Roy; Bilikere S Dwarakanath
Journal:  Front Oncol       Date:  2017-04-12       Impact factor: 6.244

4.  Identifying multiple collagen gene family members as potential gastric cancer biomarkers using integrated bioinformatics analysis.

Authors:  Zhaoxing Li; Zhao Liu; Zhiting Shao; Chuang Li; Yong Li; Qingwei Liu; Yifei Zhang; Bibo Tan; Yu Liu
Journal:  PeerJ       Date:  2020-05-25       Impact factor: 2.984

5.  Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas.

Authors:  Young Wha Koh; Dakeun Lee; Su Jin Lee
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

6.  Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer.

Authors:  In-Hye Ham; Hye Jeong Oh; Hyejin Jin; Cheong A Bae; Sang-Min Jeon; Kyeong Sook Choi; Sang-Yong Son; Sang-Uk Han; Rolf A Brekken; Dakeun Lee; Hoon Hur
Journal:  Mol Cancer       Date:  2019-03-30       Impact factor: 27.401

Review 7.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

8.  Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.

Authors:  Qing Wang; Jiahong Liang; Xianyu Hu; Songgang Gu; Qiaodong Xu; Jiang Yan
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

Review 9.  New Development of Biomarkers for Gastrointestinal Cancers: From Neoplastic Cells to Tumor Microenvironment.

Authors:  Jiajia Zhang; Shafat Quadri; Christopher L Wolfgang; Lei Zheng
Journal:  Biomedicines       Date:  2018-08-13

10.  Identification of a high-risk subtype of intestinal-type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion.

Authors:  Toru Aoyama; Gordon Hutchins; Tomio Arai; Kentaro Sakamaki; Yohei Miyagi; Akira Tsuburaya; Takashi Ogata; Takashi Oshima; Sophie Earle; Takaki Yoshikawa; Heike I Grabsch
Journal:  Cancer Med       Date:  2018-08-29       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.